| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00105-016-3907-Y |
| P698 | PubMed publication ID | 27986978 |
| P50 | author | Tilo Biedermann | Q63956049 |
| P2093 | author name string | K Brockow | |
| M Absmaier | |||
| P2860 | cites work | Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole | Q24245408 |
| Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. | Q34319335 | ||
| Adverse drug reactions: mechanisms and assessment. | Q34545321 | ||
| Epidemiology and risk factors for drug allergy | Q34976470 | ||
| Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo | Q35777131 | ||
| Epidemiology of hypersensitivity drug reactions | Q36178059 | ||
| Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis. | Q37242969 | ||
| Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome | Q37770687 | ||
| General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. | Q37780598 | ||
| Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals | Q37925159 | ||
| Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group | Q38112758 | ||
| International Consensus on drug allergy. | Q38201761 | ||
| Epidemiology of cutaneous adverse drug reactions | Q41929500 | ||
| A 6-month prospective survey of cutaneous drug reactions in a hospital setting | Q47370122 | ||
| Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 | Q57945656 | ||
| "Treating through" hypersensitivity to co-trimoxazole in AIDS patients | Q68091448 | ||
| General considerations for skin test procedures in the diagnosis of drug hypersensitivity | Q78048816 | ||
| A shortened docetaxel desensitization protocol for use in special cases | Q83460299 | ||
| Rapid desensitization for non-immediate reactions in patients with cystic fibrosis | Q83572930 | ||
| Drug allergy: an updated practice parameter | Q85175353 | ||
| Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy | Q85467978 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 29-35 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Die Dermatologie | Q15756740 |
| P1476 | title | [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?] | |
| P478 | volume | 68 |
Search more.